Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo

被引:0
|
作者
Hyo Min Park
Hui Liu
Joann Wu
Anthony Chong
Vanessa Mackley
Christof Fellmann
Anirudh Rao
Fuguo Jiang
Hunghao Chu
Niren Murthy
Kunwoo Lee
机构
[1] GenEdit Inc.,Department of Molecular and Cell Biology
[2] University of California,Department of Bioengineering
[3] Berkeley,undefined
[4] University of California,undefined
[5] Berkeley,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Engineering of the Cpf1 crRNA has the potential to enhance its gene editing efficiency and non-viral delivery to cells. Here, we demonstrate that extending the length of its crRNA at the 5′ end can enhance the gene editing efficiency of Cpf1 both in cells and in vivo. Extending the 5′ end of the crRNA enhances the gene editing efficiency of the Cpf1 RNP to induce non-homologous end-joining and homology-directed repair using electroporation in cells. Additionally, chemical modifications on the extended 5′ end of the crRNA result in enhanced serum stability. Also, extending the 5′ end of the crRNA by 59 nucleotides increases the delivery efficiency of Cpf1 RNP in cells and in vivo cationic delivery vehicles including polymer nanoparticle. Thus, 5′ extension and chemical modification of the Cpf1 crRNA is an effective method for enhancing the gene editing efficiency of Cpf1 and its delivery in vivo.
引用
收藏
相关论文
共 50 条
  • [21] CRISPR Cpf1 proteins: structure, function and implications for genome editing
    Safari, Fatemeh
    Zare, Khadijeh
    Negahdaripour, Manica
    Barekati-Mowahed, Mazyar
    Ghasemi, Younes
    CELL AND BIOSCIENCE, 2019, 9 (1):
  • [22] CRISPR Cpf1 proteins: structure, function and implications for genome editing
    Fatemeh Safari
    Khadijeh Zare
    Manica Negahdaripour
    Mazyar Barekati-Mowahed
    Younes Ghasemi
    Cell & Bioscience, 9
  • [23] Cas9 and Cpf1 gene editing of rare Cystic Fibrosis-causing mutations
    Cavusoglu-Doran, Kader
    Harrison, Patrick
    Scallan, Martina F.
    Mention, Karen
    Hollywood, Jennifer A.
    Sanz, David J.
    HUMAN GENE THERAPY, 2017, 28 (08) : A7 - A7
  • [24] Engineering CRISPR–Cpf1 crRNAs and mRNAs to maximize genome editing efficiency
    Bin Li
    Weiyu Zhao
    Xiao Luo
    Xinfu Zhang
    Chenglong Li
    Chunxi Zeng
    Yizhou Dong
    Nature Biomedical Engineering, 1
  • [25] Genome Editing of the Murine Calreticulin Gene Using the CRISPR/Cas9 and CPF1 System
    Watanabe, Daisuke
    Yasuda, Shunichiro
    Kawamata, Norihiko
    BLOOD, 2017, 130
  • [26] Genome editing of Corynebacterium glutamicum mediated with Cpf1 plus Ku/LigD
    Fa-Yu Yang
    Nan Wei
    Zhi-Hao Zhang
    Mi Wang
    Ying-Chun Liu
    Li-Fang Zhang
    Feng Gu
    Biotechnology Letters, 2021, 43 : 2273 - 2281
  • [27] Design and assessment of engineered CRISPR–Cpf1 and its use for genome editing
    Bin Li
    Chunxi Zeng
    Yizhou Dong
    Nature Protocols, 2018, 13 : 899 - 914
  • [28] Multiplex Genome Editing of Human Pluripotent Stem Cells Using Cpf1
    Ma, Haiting
    BIO-PROTOCOL, 2024, 14 (22):
  • [29] CRISPR/Cpf1 enables fast and simple genome editing of Saccharomyces cerevisiae
    Verwaal, Rene
    Buiting-Wiessenhaan, Nathalie
    Dalhuijsen, Sacha
    Roubos, Johannes A.
    YEAST, 2018, 35 (02) : 201 - 211
  • [30] Genome editing of Corynebacterium glutamicum mediated with Cpf1 plus Ku/LigD
    Yang, Fa-Yu
    Wei, Nan
    Zhang, Zhi-Hao
    Wang, Mi
    Liu, Ying-Chun
    Zhang, Li-Fang
    Gu, Feng
    BIOTECHNOLOGY LETTERS, 2021, 43 (12) : 2273 - 2281